Document:

Form of Award Agreement under the Long-Term Incentive Plan of the Company

 Exhibit 10.1 
 IMPORTANT—ACTION REQUIRED: In order for your FY12 stock awards to become effective, you must use the voting button at the top of this email, click on “I agree to the
award terms & conditions” and reply by 29 February 2012. Failure to respond by this date will result in forfeiture of your award. 
 Company Confidential Communication to: «First_name» «Last_name» 
 I would
like to take this opportunity to thank you for your commitment to the Company both in the past and most importantly looking forward. You play an important role in the future performance of our Company. 

One of the priorities of our management compensation program is to provide you with the opportunity to share in the long-term success of Air Products. As
a result, I am pleased to present your 2012 stock awards under the Company’s Long-Term Incentive Plan. These awards make up the long-term component of your total pay package and link your personal wealth to the performance of the Company.

 Your 2012 awards are valued at $<Tot Value> and include: 

 

	 	•	 	 A Nonstatutory Stock Option to purchase «Stock_Option» shares of Common Stock at a purchase price of $82.64 per share, which is the
1 December 2011 closing sale price of a share of Common Stock, valued at $«SO Value»; and 

  

	 	•	 	 An award of «RSU» 4-Year Restricted Shares of Company Common Stock issued to you as of 1 December 2011 valued at $<RS
Value>; and 

  

	 	•	 	 «Perf_Share» Deferred Stock Units with a three year performance period valued at $<PS Value>, each Unit (a
“Performance Share”) being equivalent in value to one share of Common Stock. 

 Thank you again for your
dedication and on-going contributions to Air Products. 
 Your 2012 Awards are subject to and contingent upon your agreement to the attached
conditions described in Exhibit A. Please read these conditions carefully, particularly the descriptions of “Prohibited Activities”. This letter, together with its Exhibit, constitutes the agreement governing your 2012 Awards (“Awards
Agreement”). Your 2012 Awards are also at all times subject to the applicable provisions of the Long-Term Incentive Plan (the “Plan”) and to any determinations made by the Management Development and Compensation Committee of the
Company’s Board of Directors (the “Committee”) or its delegate, with respect to your 2012 Awards as contemplated or permitted by the Plan or the Conditions. The Committee has established a one-year holding period for a portion of your
Stock Options as further explained in Section 7 of Exhibit A. 
 Neither your 2012 Awards, this Award Agreement or the Plan constitute a
contract of employment; nor do they guarantee your continued employment for any period required for all or any of your 2012 Awards to vest, become exercisable, be earned or be paid out. Except as otherwise indicated all capitalized words used in
this Awards Agreement have the meanings described in the Plan. 

 WITNESSETH the due execution of this Awards Agreement at Allentown, Pennsylvania
effective as of the 1st day of December 2011 intending to
be legally bound hereby. 
  

			
	AIR PRODUCTS AND CHEMICALS, INC.
		
	By:	 	

		 	John E. McGlade

 Exhibit 

 EXHIBIT A 
 AIR PRODUCTS AND CHEMICALS, INC. (the “Company”) 
 LONG-TERM
INCENTIVE PLAN 
 FY2012 AWARD AGREEMENT 

 

	1.	As described in the foregoing grant letter, you are hereby granted FY2012 Awards consisting of Stock Options (“Options”), Restricted Shares of Company Common
Stock (“Restricted Shares”), and Deferred Stock Units to be called “Performance Shares” under the Air Products and Chemicals, Inc. Long-Term Incentive Plan (the “Plan”). The Options are “Nonstatutory Stock
Options” as described in Section 6 of the Plan. The Restricted Shares are described in Section 8 of the Plan. The Deferred Stock Units are described in Section 9 of the Plan. The Management Development and Compensation Committee
of the Company’s Board of Directors (the “Committee”) has approved these Awards subject to the applicable provisions of the Plan and the terms of this Agreement, and contingent upon your acceptance of this Agreement. Except as noted
herein, all capitalized terms used in this Agreement have the meaning ascribed to them in the Plan. A copy of the Plan is available from the Corporate Secretary’s Office of the Company, 7201 Hamilton Boulevard, Allentown,
PA 18195-1501. 

  

	2.	Each Option entitles you to purchase one share of Company Common Stock (“Share”) at a purchase price of $82.64 (the “Grant Price”) as described
below. You can first purchase Shares as follows: (i) up to one-third of the Shares may be purchased on or after 1 December 2012 and (ii) up to an additional one-third of such Shares may be purchased on or after 1 December 2013
and 2014, respectively. The Options are granted as of 1 December 2011 and will continue for a period of ten (10) years from such grant date and will expire and no longer be exercisable after the close of the New York Stock Exchange on
1 December 2021. Any Option which is unexercised as of the close of the New York Stock Exchange on 1 December 2021 and which has not terminated in accordance with Paragraph 4 of this Agreement, will be settled by a Net Exercise
whereby the Company will issue you shares of Common Stock equal to the number of shares covered by the Option, reduced by the number of whole shares that has a Fair Market Value equal to or in excess of the sum of the aggregate Grant Price of the
Options and the minimum statutory withholding tax obligation arising from the Net Exercise of the Options, and shall remit any excess of the Fair Market Value of such shares to you. 

	3.	You may purchase Shares covered by an Option by providing to the Company’s agent, Fidelity Stock Plan Services, LLC or any successor thereto
(“Fidelity”), notice of exercise of the Option in a form designated by Fidelity and the Grant Price of the Shares. Payment of the Grant Price and applicable taxes may be made in cash or by providing an irrevocable exercise notice coupled
with irrevocable instructions to Fidelity to simultaneously sell all or portion of the Shares and deliver to the Company on the settlement date the portion of the proceeds representing the Grant Price and any taxes to be withheld. Payment of the
Grant Price may also be made by delivery or attestation of ownership of other Shares of Common Stock owned by you with a Fair Market Value equal to the Grant Price, in which case the number of Shares acquired in the exercise will be reduced by an
amount equal in value to the amount of any taxes required to be withheld and by the number of Shares as to which ownership was attested. 

  

	4.	Your Options terminate as of the close of business on the last day of your employment with the Company and all its Subsidiaries, unless your employment ends due to your
death, Disability, or Retirement on or after 30 November 2012. Upon your, death, Disability, or Retirement on or after 30 November 2012, your Options will not terminate and any unexercisable portion of the Options will be extended until
its expiration (that is, will become and be exercisable) as if you have continued to be an active employee of the Company or a Subsidiary. Notwithstanding the above, if your employment with the Company or a Subsidiary is involuntarily terminated by
the Company on or after 30 November 2012 due to action necessitated by business conditions, including, but not limited to, job eliminations, workforce reductions, divestitures of facilities, assets or businesses, sale by the Company of a
Subsidiary, or plant closing, your exercisable Options will not be immediately terminated but will continue to be exercisable in accordance with their terms for six months following your last day of employment with the Company or a Subsidiary, and
shall terminate at the end of such six month period. 

  

	5.	In the event of a Change in Control, the Options shall become exercisable on the later of the Change in Control or 1 June 2012. In the event of any other change in
the outstanding shares of the Common Stock of the Company or the occurrence of certain other events described in Section 12 of the Plan, an equitable adjustment shall be made in the number or kind of Shares or the Grant Price for Shares covered
by your Options. 

	6.	Options are nonassignable and nontransferable except to your Designated Beneficiary or by gift to family members or to trusts of which only family members are
beneficiaries. Such transfers by gift can be made only after the Option has become exercisable and subject to such administrative procedures and to such restrictions and conditions as the officers of the Company shall determine to be consistent with
the purposes of the Plan and the interests of the Company and/or to be necessary or appropriate for compliance with all applicable tax and other legal requirements. Subject to the foregoing, you may transfer Options by gift only by delivering to the
Company at its principal offices in Allentown, Pennsylvania, written notice of the intent to transfer the Options on forms to be provided by the Company. 

  

	7.	In accepting the Options, you agree that, as long as you are actively employed as an Executive Officer by the Company or one of its Subsidiaries, you will retain, for
at least one year, beneficial ownership of 50% of the net Shares (after payment of the exercise price, taxes, and commissions) that you receive upon an exercise of the Option. 

 

	8.	The Restricted Shares shall be issued to you as of 1 December 2011. Upon issuance of the Restricted Shares, you will be the holder of record of such shares and
shall have all the rights of a shareholder with respect to the Restricted Shares, including the right to vote such Restricted Shares and receive all dividends or other distributions paid with respect to the Restricted Shares, subject to the
restrictions contained in Paragraph 9 below. In the event of any change in the outstanding shares of Common Stock of the Company or the occurrence of certain other events described in Section 12 of the Plan, an equitable adjustment of the
number of Restricted Shares covered by this Agreement shall be made consistent with the impact of such change or event upon the rights of the Company’s other shareholders, and any additional Shares of Common Stock issued to you as a result of
such adjustment shall be Restricted Shares subject to this Agreement, including, without limitation, the restrictions contained in Paragraph 9. 

  

	9.	 The “Restriction Period” with respect to the Restricted Shares shall be the period beginning 1 December 2011 and ending on the earliest
of 1 December 2015; your death, Disability, or Retirement on or after 30 November 2012, or a Change in Control of the Company. During the Restriction Period, neither the Restricted Shares nor any interest in the Restricted Shares may be
sold, assigned, transferred, encumbered, or otherwise disposed of by you; provided however, that such Restricted Shares may be used to pay the exercise price by attestation upon your exercise of Stock Options, with the stipulation that the
Restricted Shares attested will remain subject to the restrictions of this Paragraph 9 and the terms of this Agreement. If 

	 	
your employment by the Company and all its Subsidiaries is terminated for any reason prior to 30 November 2012, or for any reason other than death, Disability, or Retirement prior to
30 November 2015, the Restricted Shares shall be forfeited in their entirety; provided that, in the event of a Change in Control of the Company, your rights to the Restricted Shares shall become immediately transferable and nonforfeitable. At
the end of the Restriction Period, all nonforfeited Restricted Shares shall become transferable and otherwise be regular Shares. 

  

	10.	At the end of the Restriction Period, and, if earlier, upon your election to include the value of the Restricted Shares in your federal taxable income pursuant to
Internal Revenue Code Section 83(b), payment of taxes required to be withheld by the Company must be made. When taxation occurs at the end of the Restriction Period, applicable taxes will be withheld by reducing the number of the Restricted
Shares issued to you without restriction by an amount equal in market value to the taxes required to be withheld. In the event you make a Section 83(b) election, applicable taxes must be paid in cash to the Company at the time the election is
filed with the Internal Revenue Service. 

  

	11.	In the event your employment is terminated due to your death on or after 30 November 2012, the Restricted Shares shall be transferred free of restriction, reduced
by any applicable taxes, to your Designated Beneficiary or, if none, to your legal representative as soon as administratively practical after your death. 

  

	12.	The Performance Shares granted to you will be earned in accordance with the formula indicated on the Earn Out Schedule (Attachment) corresponding to the level of
average Earnings Per Share Growth and spread of Return on Capital Employed over the Company’s cost of capital achieved for the three fiscal year performance period beginning 1 October 2011 and ending 30 September 2014 (the
“Performance Period”). Subject to the forfeiture conditions contained in Paragraph 13 and to Paragraph 18, each earned Performance Share will entitle you to receive, at the end of the Deferral Period (as defined below), one Share.

  

	13.	 The Deferral Period will begin on the date of this Agreement and will end on 30 November 2014. If your employment by the Company and all its
affiliates is terminated for any reason prior to 30 November 2012, all your Performance Shares will be automatically forfeited in their entirety. If your employment by the Company and all its affiliates terminates on or after 30 November
2012, but during the Deferral Period, other than due to death, Disability, or Retirement, you will 

	 	
forfeit all of your Performance Shares. If your employment by the Company and all its affiliates is terminated on or after 30 November 2012, but during the Deferral Period, due to death,
Disability, or Retirement, you will not forfeit a pro-rata portion of your earned Performance Shares which portion in each case shall be based on the number of full months you worked during the Performance Period. 

 

	14.	Performance Shares earned and not forfeited shall be paid in Shares, reduced by the number of Shares equal in market value to any applicable taxes, as soon as
administratively practical after the end of the Deferral Period. No cash dividends or other amounts shall be payable with respect to the Performance Shares during the Deferral Period. At the end of the Deferral Period, for each earned and
nonforfeited Performance Share, the Company will also pay to you a cash payment equal to the dividends which would have been paid on a Share during the Deferral Period (“Dividend Equivalents”), net of applicable taxes.

  

	15.	If your employment by the Company or a Subsidiary terminates during the Deferral Period due to death, payment in respect of earned Performance Shares that are not
forfeited and of related Dividend Equivalents shall be made, as soon as practical after the Deferral Period, to your Designated Beneficiary or, if none, your legal representative, net of applicable taxes. 

 

	16.	In the event of any change in the outstanding Shares of Common Stock of the Company or the occurrence of certain other events as described in Section 12 of the
Plan, an equitable adjustment of the number of Performance Shares covered by this Agreement shall be made as provided in the Plan. 

  

							
	17.	  	 	(a	) 	 	Notwithstanding anything to the contrary above, any Performance Shares earned or paid and any related Dividend Equivalents paid to you may be rescinded within three years of
their payment in the event: the earning of such Performance Shares is predicated upon the achievement of financial results that are subsequently the subject of a restatement; the Committee determines in its sole discretion that you engaged in
misconduct that caused or partially caused the need for the restatement; and the Performance Shares would not have been earned or a lesser amount of Performance Shares would have been earned based upon the restated financial results. In the event of
any such rescission, you shall pay to the Company the amount of any gain realized or payment received as a result of any rescinded payment, in such manner and on such terms as may be required, and the Company shall be entitled to reduce the amount
of any amount owed to you by the Company or any Subsidiary by such gain or payment.

	 	  (b)	Notwithstanding any other provisions of this Agreement, in the event the Company is required to prepare an accounting restatement due to its material noncompliance with
any financial reporting requirement, the Company may recover from you any amounts or awards which it is required to recover under Section 10D of the Securities Exchange Act of 1934 or any other applicable law or securities exchange listing
standard. 

  

	18.	In the event the Company determines, in its sole discretion, that you have engaged in a “Prohibited Activity” (as defined below), at any time during your
employment, or within one year after termination of your employment from the Company or any Subsidiary, the Company may forfeit, cancel, modify, rescind, suspend, withhold, or otherwise limit or restrict any unexpired, unpaid, unexercised, or
deferred Awards outstanding under this Agreement, and any exercise, payment, or delivery of an Award or Shares pursuant to such an Award may be rescinded within six months after such exercise, payment, or delivery. In the event of any such
rescission, you shall pay to the Company the amount of any gain realized or payment received as a result of the rescinded exercise, payment, or delivery, in such manner and on such terms as may be required by the Company, and the Company shall be
entitled to reduce the amount of any amount owed to you by the Company or any Subsidiary by such gain or payment. 

The Prohibited Activities are: 
  

	 	(a)	Your making any statement, written or verbal, in any forum or media, or taking any action in disparagement of the Company or any Subsidiary or affiliate thereof
(hereinafter, the “Company”), including but not limited to negative references to the Company or its products, services, corporate policies, current or former officers or employees, customers, suppliers, or business partners or associates;

  

	 	(b)	Your publishing any opinion, fact, or material, delivering any lecture or address, participating in any film, radio broadcast, television transmission, internet
posting, social media, and/or any other electronic media;, or communicating with any representative of the media relating to, confidential matters regarding the business or affairs of the Company; 

 

	 	(c)	 Your failure to hold in confidence all Trade Secrets of the Company that came into your knowledge during your employment by the Company, or disclosing,
publishing, or making use of at any time such Trade Secrets, where the term “Trade Secret” means any technical or nontechnical data, formula, pattern, compilation, program, device, method, technique, drawing, process, financial

	 	
data, financial plan, product plan, list of actual or potential customers or suppliers, or other information similar to any of the foregoing, which (i) derives economic value, actual or
potential, from not being generally known to and not being readily ascertainable by proper means by, other persons who can derive economic value from its disclosure or use, and (ii) is the subject of efforts that are reasonable under the
circumstances to maintain its secrecy; 

  

	 	(d)	Your failure to hold in confidence all Confidential Information of the Company that comes into your knowledge during your employment by the Company, or disclosing,
publishing, or making use of such Confidential Information, where the term “Confidential Information” means any data or information, other than Trade Secrets, that is valuable to the Company and not generally known to the public or to
competitors of the Company; 

  

	 	(e)	Your failure, in the event of your termination of employment for any reason, promptly to deliver to the Company all memoranda, notes, records, manuals, or other
documents, including all electronic or other copies of such materials and all documentation prepared or produced in connection therewith, containing Trade Secrets or Confidential Information regarding the Company’s business, whether made or
compiled by you or furnished to you by virtue of your employment with the Company; or your failure promptly to deliver to the Company all vehicles, computers, credit cards, telephones, handheld electronic devices, office equipment, and other
property furnished to you by virtue of your employment with the Company; 

  

	 	(f)	Your rendering of services for any organization as an employee, officer, director, consultant, advisor, agent, broker, independent contractor, principal, or partner, or
engaging directly or indirectly in any business which, in the sole judgment of the Company, is or becomes competitive with the Company during the one (1) year period following the termination of your employment; or directly or indirectly
soliciting any customer, supplier, contractor, employee, agent, or consultant of the Company with whom you had contact during the last two years of your employment with the Company or became aware of through your employment with the Company, to
cease doing business with, or to terminate their employment or business relationship with, the Company; or 

  

	 	(g)	Your violation of any written policies of the Company applicable to you, including, without limitation, the Company’s insider trading policy.

 The provisions of this Section 18 are in addition to, and shall not supersede, the terms of your Employee
Patent and Confidential Information Agreement entered at the time you were employed by the Company. You expressly acknowledge and affirm that the foregoing provisions of this Section 18 are material and important terms of this Agreement and
that your agreement to be bound by the terms of this Section 18 is a condition precedent to your FY2012 Awards. 

	19.	All determinations regarding the interpretation, construction, enforcement, waiver, or modification of this Agreement and/or the Plan shall be made in the
Company’s sole discretion or, in the case of Executive Officer Awards, by the Committee in its sole discretion and shall be final and binding on you and the Company. Determinations made under this Agreement and the Plan need not be uniform and
may be made selectively among individuals, whether or not such individuals are similarly situated. 

  

	20.	If any of the terms of this Agreement in the opinion of the Company conflict or are inconsistent with any applicable law or regulation of any governmental agency having
jurisdiction, the Company reserves the right to modify this Agreement to be consistent with applicable laws or regulations. 

  

	21.	You understand and acknowledge that the Company holds certain personal information about you, including but not limited to your name, home address, telephone number,
date of birth, social security number, salary, nationality, job title, and details of all Shares awarded, cancelled, vested, unvested, or outstanding (the “personal data”). Certain personal data may also constitute “sensitive personal
data” within the meaning of applicable local law. Such data include but are not limited to the information provided above and any changes thereto and other appropriate personal and financial data about you. You hereby provide explicit consent
to the Company and any Subsidiary to process any such personal data and sensitive personal data. You also hereby provide explicit consent to the Company and any Subsidiary to transfer any such personal data and sensitive personal data outside the
country in which you are employed, and to the United States. The legal persons for whom such personal data are intended are the Company and any third party providing services to the Company in connection with the administration of the Plan.

  

	22.	 By accepting this award, you acknowledge having received and read the Plan Prospectus, and you consent to receiving information and materials in
connection with this Award or any subsequent awards under the Company’s long-term performance plans, including without limitation any prospectuses and plan documents, by any means of electronic delivery available now and/or in the future
(including without limitation by e-mail, by Website access, and/or by facsimile), such consent to remain in effect unless and until revoked in writing by you. This 

	 	
Agreement and the Plan, which is incorporated herein by reference, constitute the entire agreement between you and the Company regarding the terms and conditions of this Award.

  

	23.	You submit to the exclusive jurisdiction and venue of the federal or state courts of the Commonwealth of Pennsylvania to resolve all issues that may arise out of or
relate to and all determinations made under this Agreement. This Agreement shall be governed by the laws of the Commonwealth of Pennsylvania, without regard to conflicts or choice of law rules or principles. 

 

	24.	If any court of competent jurisdiction finds any provision of this Agreement, or portion thereof, to be unenforceable, that provision shall be enforced to the maximum
extent permissible so as to effect the intent of the parties, and the remainder of this Agreement shall continue in full force and effect. 

  

	25.	Neither your FY2012 Awards, this Award Agreement, nor the Plan constitute a contract of employment; nor do they guarantee your continued employment for any period
required for all or any of your Options to vest or become exercisable. 

 Attachment 

2012 Performance Share Earn Out Schedule 
 (PERFORMANCE SHARES AWARDED) x (PAYOUT FACTOR) = 
 (PERFORMANCE SHARES EARNED)

 The Payout Factor is determined as follows: 
  

									
	 33%
	  		  	67%	  		  	Payout
	 EPS Growth
	  	+	  	ROCE Spread	  	=	  	Factor*
	 Factor
	  		  	Factor	  		  	

  

	 	*	The Payout Factor will be increased by 15 percentage points to determine the maximum payout. The Committee, in its discretion, may decrease the actual Payout Factor by
up to 30 percentage points from the maximum payout (15 percentage points from the calculated Payout Factor). 

 The EPS Growth and
ROCE Spread Factors are determined from the following schedules: 
  

			
	 EPS Growth(1)
	 	 EPS

Growth Factor

	 -10%
	 	    0%
	   0%
	 	  35%
	   4%
	 	  50%
	   7%
	 	  80%
	   9%
	 	100%
	 10%
	 	120%
	 11%
	 	130%
	 13%
	 	160%
	 15%
	 	180%
	 16%
	 	200%

  

			
	 ROCE Spread

(ROCE over

Cost of Capital)
	 	 ROCE

Spread

Factor(2)

	 <0%
	 	    0%
	   0%
	 	  50%
	 +3%
	 	100%
	 +5%
	 	200%

  

	(1) 	 EPS growth is the average of annual growth in earnings per share over the prior year for each of fiscal years 2012, 2013, and 2014.

	(2) 	 ROCE spread is the average of the difference between the Company’s Return on Capital Employed and cost of capital for each of fiscal years 2012,
2013, and 2014.Exhibit 10.1

 Exhibit 10.1 
 Western Digital Corporation 
 Summary of Compensation Arrangements 

for 
 Named
Executive Officers and Directors 
 NAMED EXECUTIVE OFFICERS 
 Base Salaries. The current annual base salaries for the current executive officers of Western Digital Corporation (the “Company”) who were named in the Summary Compensation Table in the
Company’s Proxy Statement that was filed with the Securities and Exchange Commission in connection with the Company’s 2011 Annual Meeting of Stockholders (the “Named Executive Officers”) are as follows: 

 

			September 30,			September 30,	
	 Named Executive Officer
	    	 Title
	    	Current
Base Salary	 
	 John F. Coyne
	    	President and Chief Executive Officer	    	$	1,000,000	  
	 Timothy M. Leyden
	    	Chief Operating Officer	    	$	600,000	  
	 Wolfgang U. Nickl
	    	Senior Vice President and Chief Financial Officer	    	$	400,000	  
	 James J. Murphy
	    	Executive Vice President, Worldwide Sales and Sales Operations	    	$	425,000	  
	 James K. Welsh III
	    	Executive Vice President and GM, Branded Products	    	$	400,000	  
	 James D. Morris
	    	Executive Vice President and GM, Storage Products	    	$	400,000	  

 Semi-Annual Bonuses. Under the Company’s Incentive Compensation Plan (the “ICP”),
the Named Executive Officers are also eligible to receive semi-annual cash bonus awards that are determined based on the Company’s achievement of performance goals pre-established by the Compensation Committee (the “Committee”) of the
Company’s Board of Directors as well as other discretionary factors. The ICP, including the performance goals established by the Committee for the first half of fiscal 2012, are further described in the Company’s current report on form 8-K
filed with the Securities and Exchange Commission on August 15, 2011, which is incorporated herein by reference. 

Additional Compensation. The Named Executive Officers are also eligible to receive equity-based incentives and discretionary
bonuses as determined from time to time by the Committee, are entitled to participate in various Company plans, and are subject to other written agreements, in each case as set forth in exhibits to the Company’s filings with the Securities and
Exchange Commission. In addition, the Named Executive Officers may be eligible to receive perquisites and other personal benefits as disclosed in the Company’s Proxy Statement filed with the Securities and Exchange Commission in connection with
the Company’s 2011 Annual Meeting of Stockholders. 

 DIRECTORS 
 Annual Retainer and Committee Retainer Fees. The following table sets forth the current annual retainer and committee membership fees payable to each of the Company’s non-employee
directors: 
  

				September 30,	
	 Type of Fee
	    	Current Annual
Retainer Fees	 
	 Annual Retainer
	    	$	75,000	  
	 Lead Independent Director Retainer
	    	$	20,000	  
	 Non-Executive Chairman of Board Retainer
	    	$	100,000	  
	 Additional Committee Retainers
	    			
	 • Audit Committee
	    	$	10,000	  
	 • Compensation Committee
	    	$	5,000	  
	 • Governance Committee
	    	$	2,500	  
	 Additional Committee Chairman Retainers
	    			
	 • Audit Committee
	    	$	15,000	  
	 • Compensation Committee
	    	$	10,000	  
	 • Governance Committee
	    	$	7,500	  

 The retainer fee to the Company’s lead independent director referred to above is paid only if the
Chairman of the Board is an employee of the Company. Effective commencing with the Company’s 2010 Annual Meeting of Stockholders, the annual retainer fees are paid immediately following the Annual Meeting of Stockholders. 

Non-employee directors do not receive a separate fee for each Board of Directors or committee meeting they attend. However, the Company
reimburses all non-employee directors for reasonable out-of-pocket expenses incurred to attend each Board of Directors or committee meeting. Mr. Coyne, who is an employee of the Company, does not receive any compensation for his service on the
Board or any Board committee. 
 Additional Director Compensation. The Company’s non-employee directors are also
entitled to participate in the following other Company plans as set forth in exhibits to the Company’s filings with the Securities and Exchange Commission: Non-Employee Director Option Grant Program and Non-Employee Director Restricted Stock
Unit Grant Program, each as adopted under the Company’s Amended and Restated 2004 Performance Incentive Plan; Amended and Restated Non-Employee Directors Stock-for-Fees Plan; and Deferred Compensation Plan.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00198-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00198-of-00352.parquet"}]]